Although highly sensitive, SATB2 is weakly positive in focal areas of some other tumors, such as pulmonary adenocarcinoma, pulmonary squamous carcinoma, bladder and ureteral tumors, and adenocarcinoma of the cervix, endometrium, and ovary [13]. The gene discussed is SATB2; the disease is ureter neoplasm.